Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
6.89
-0.38 (-5.23%)
At close: Feb 5, 2026, 4:00 PM EST
6.95
+0.06 (0.87%)
After-hours: Feb 5, 2026, 7:19 PM EST
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $502.88 million as of February 5, 2026. Its market cap has increased by 211.54% in one year.
Market Cap
502.88M
Enterprise Value
389.31M
1-Year Change
211.54%
Ranking
Category
Stock Price
$6.89
Market Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has increased from $271.36M to $502.88M, an increase of 85.32%. That is a compound annual growth rate of 31.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 530.62M | -26.79% |
| Dec 31, 2025 | 724.76M | 232.99% |
| Dec 31, 2024 | 217.65M | -39.13% |
| Dec 29, 2023 | 357.58M | 31.78% |
| Nov 3, 2023 | 271.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evommune | 582.57M |
| Replimune Group | 578.91M |
| Keros Therapeutics | 562.71M |
| Contineum Therapeutics | 555.61M |
| LB Pharmaceuticals | 551.77M |
| REGENXBIO | 549.77M |
| Lyell Immunopharma | 547.46M |
| Lexicon Pharmaceuticals | 534.87M |